interpretation of pulmonary function tests (pfts)
TRANSCRIPT
![Page 1: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/1.jpg)
INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)
Anna Neumeier, MD
Assistant Professor, Department of Pulmonary Sciences and Critical Care Medicine
ACP
February 2020
![Page 2: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/2.jpg)
![Page 3: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/3.jpg)
LEARNING OBJECTIVES
1. Describe the clinical indications for pulmonary function testing
2. Understand the physiology of the core pulmonary function tests: spirometry, lung volumes and DLCO
3. Apply an organized approach to interpreting pulmonary function tests
4. Identify obstructive, restrictive, mixed obstructive-restrictive and pulmonary vascular patterns of abnormalities on pulmonary function testing.
![Page 4: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/4.jpg)
INDICATIONS FOR PFTS
• Evaluation of patients presenting with dyspnea
• Evaluating disease severity and monitoring response to treatment
• Determine fitness for surgery
• *thoracic surgery/lung resection
![Page 5: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/5.jpg)
PFTS: AVAILABLE MEASURES
• Spirometry
• Airflow (how much air, how fast)
• (Static) Lung volumes
• Volume (how much air)
• Diffusing Capacity/DLCO
• Gas exchange (how effective)
• Other testing:
• Airway responsiveness
• Respiratory muscle strength testing
• Compliance of the lungs
![Page 6: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/6.jpg)
A PHYSIOLOGY REFRESHER:LUNG VOLUMES AND CAPACITIES
![Page 7: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/7.jpg)
Al-Askhar. Cleveland Clinic Journal of Medicine. 2003
![Page 8: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/8.jpg)
![Page 9: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/9.jpg)
![Page 10: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/10.jpg)
![Page 11: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/11.jpg)
![Page 12: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/12.jpg)
![Page 13: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/13.jpg)
![Page 14: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/14.jpg)
![Page 15: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/15.jpg)
![Page 16: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/16.jpg)
Al-Askhar. Cleveland Clinic Journal of Medicine. 2003
![Page 17: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/17.jpg)
AN APPROACH TO PFT INTERPRETATION
![Page 18: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/18.jpg)
STEP 1: CONFIRM PATIENT DEMOGRAPHIC DATA
![Page 19: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/19.jpg)
DEFINING NORMAL AND ABNORMAL VALUES
• Interpretation involves comparison of the patient’s values with reference values (Crapo Hsu, NHANES III, GLI)
• Dependent on age, sex, race and ethnicity, height
• African Americans have values that are 12% lower than Caucasians
• Threshold for Normal
• 80-120% predicted
• age-adjusted LLN
(lower limits of normal)
![Page 20: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/20.jpg)
DEFINING OBSTRUCTION WITH FEV1/FVC RATIO:FIXED 0.7 CUT-OFF VS. AGE-ADJUSTED LLN
![Page 21: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/21.jpg)
STEP II: IS THE TEST OF ADEQUATE QUALITY?
Acceptability and
Reproducibility
![Page 22: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/22.jpg)
ACCEPTABILITY
Free from artifacts (cough, glottic closure)
1
Free from leaks
2
Good start
3
Good Effort
4
Examine the flow volume loop and the flow time curve
![Page 23: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/23.jpg)
AJRCCM.1994
![Page 24: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/24.jpg)
REPRODUCIBILITY
3 acceptable maneuvers with at least 2 that are repeatable within 0.15L of each other (0.1L if FVC<1L)
AJRCCM.1994
![Page 25: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/25.jpg)
STEP III: FLOW VOLUME LOOPS
![Page 26: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/26.jpg)
Obstructive Disease
Restrictive Disease
Extrathoracic airflow obstruction
Fixed airflow obstruction
![Page 27: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/27.jpg)
STEP IV: INTERPRET THE PFTS WITH A SYSTEMATIC APPROACH
Recognize the pattern and classify the severity of abnormality
![Page 28: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/28.jpg)
PATTERNS OF DISEASE WITH
PFTS
• Asthma • COPD (emphysema, chronic
bronchitis)
• Bronchiolitis/Bronchiectasis
ObstructiveFEV1/FVC <0.7
(or <LLN)
• Interstitial lung disease
• Neuromuscular weakness
• Pleural disease
• Chest wall deformities
• Obesity
RestrictiveFEV1/FVC
reduced with low lung volumes*
• Both obstructive and restrictive elementsMixed
![Page 29: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/29.jpg)
Obstructive
Pattern
Restrictive
Pattern
Forced Vital
Capacity (FVC)
Decreased or
normal
Decreased
Forced Expiratory
Volume in 1 second
(FEV1)
Decreased Decreased or
normal
FEV1/FVC ratio Decreased Normal
Total Lung Capacity Normal or
Increased
Decreased
![Page 30: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/30.jpg)
Al-Askhar. Cleveland Clinic Journal of Medicine. 2003
Step 1: Is there obstruction?
Step 2: how severe is the obstruction?
Step 4: Interpret lung volumes
Full lung volumes are necessary to assess whether restriction is present
Step 3: Is there response to bronchodilator?
Look at additional supplemental testing (DLCO, walk testing, bronchoprovocation)
![Page 31: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/31.jpg)
BRONCHODILATOR RESPONSE
• Improvement in FEV1 or FVC by 12% and 200cc
• Normalization of spirometry after bronchodilator supports the diagnosis of asthma
• The lack of BD response does not preclude a clinical response to bronchodilator therapy
![Page 32: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/32.jpg)
CASES
![Page 33: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/33.jpg)
CASE 1:
A 29 y/o woman presents to your clinic with episodes of shortness of breath, chest tightness and wheezing during the springtime. You interpret her PFTs as:
a. Normal spirometry and lung volumes
b. Obstructive pattern
c. Restrictive pattern
d. Mixed obstructive restrictive pattern
![Page 34: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/34.jpg)
![Page 35: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/35.jpg)
Al-Askhar. Cleveland Clinic Journal of Medicine. 2003
![Page 36: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/36.jpg)
CASE 1:
A 29 y/o woman presents to your clinic with episodes of shortness of breath, chest tightness and wheezing during the spring time. You interpret her PFTs as:
a. Normal spirometry and lung volumes
b. Obstructive pattern
c. Restrictive pattern
d. Mixed obstructive restrictive pattern
Normal- no obstruction
Normal
Normal
![Page 37: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/37.jpg)
CASE 1 CONTINUED:
Based on these lung function tests, your suspicion that this patient has asthma is:
a. Decreased, normal lung function test rules out asthma
b. Unchanged, her clinical history is suggestive and many patients with asthma have normal spirometry
c. I can’t tell as a bronchodilator response was not assessed
![Page 38: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/38.jpg)
![Page 39: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/39.jpg)
PFTS TO EVALUATE FOR ASTHMA
• Spirometry both pre- and post-bronchodilator
• Bronchodilator response supports diagnosis
• Normal spirometry does not exclude a diagnosis of asthma
• Additional steps to assess for asthma:
• Bronchoprovocation testing (methacholine challenge)
• High-negative predictive value
• Empiric therapy
• Evaluation for asthma mimickers and look at flow volume loop
![Page 40: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/40.jpg)
CASE 2: A 67 Y/O MAN WITH COUGH
![Page 41: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/41.jpg)
![Page 42: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/42.jpg)
CASE 2:
You interpret his PFTs as:
a. Normal spirometry and lung volumes
b. Obstructive pattern
c. Restrictive pattern
d. Mixed obstructive restrictive pattern
![Page 43: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/43.jpg)
CASE 2: A 67 Y/O MAN WITH COUGH
![Page 44: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/44.jpg)
![Page 45: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/45.jpg)
Al-Askhar. Cleveland Clinic Journal of Medicine. 2003
![Page 46: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/46.jpg)
CASE 2:
You interpret his PFTs as:
a. Normal spirometry and lung volumes
b. Obstructive pattern
c. Restrictive pattern
d. Mixed obstructive restrictive pattern
![Page 47: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/47.jpg)
CASE 2 CONTINUED:
All of the following conditions could be causes of his restrictive lung disease except:
a. Interstitial lung disease
b. Pleural effusions
c. Kyphoscoliosis
d. Neuromuscular weakness
e. Obesity
![Page 48: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/48.jpg)
CASE 2: A 67 Y/O MAN WITH COUGH
![Page 49: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/49.jpg)
![Page 50: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/50.jpg)
CASE 2 CONTINUED:
All of the following conditions could be causes of his restrictive lung disease except:
a. Interstitial lung disease
b. Pleural effusions
c. Kyphoscoliosis
d. Neuromuscular weakness
e. Obesity
![Page 51: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/51.jpg)
LUNG VOLUMES- PATTERNS TO DIFFERENTIATE RESTRICTIVE DISEASE
Cause of Restriction Pattern of lung volume
abnormality
Intrinsic Lung Disease
(interstitial lung disease,
pulmonary fibrosis)
Low VC and low RV
Neuromuscular Disease Low VC and high RV
Chest wall restriction
(kyphoscoliosis)
Low VC and low RV
Obesity Low FRC and low ERV
![Page 52: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/52.jpg)
CASE 3: A 77 Y/O MAN WITH DYSPNEA AND HYPOXEMIA
![Page 53: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/53.jpg)
![Page 54: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/54.jpg)
CASE 3
• You interpret these PFTs as:
a. Normal spirometry and lung volumes
b. Obstructive pattern
c. Restrictive pattern
d. Mixed obstructive restrictive pattern
![Page 55: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/55.jpg)
CASE 3: A 77 Y/O MAN WITH DYSPNEA AND HYPOXEMIA
![Page 56: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/56.jpg)
![Page 57: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/57.jpg)
Severity of Airflow Obstruction:FEV1 >80%- mildFEV1 50-80%- moderateFEV1 30- 50% severeFEV1 <30% very severe
![Page 58: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/58.jpg)
CASE 3
• You interpret these PFTs as:
a. Normal spirometry and lung volumes
b. Obstructive pattern
c. Restrictive pattern
d. Mixed obstructive restrictive pattern
![Page 59: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/59.jpg)
LUNG VOLUMES: HYPERINFLATION AND AIR TRAPPING
Hyperinflation= TLC>120%
Air trapping with RV>140%
![Page 60: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/60.jpg)
![Page 61: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/61.jpg)
CASE 4
• A 76 y/o man presents with hypoxemia, you order PFTs which show:
![Page 62: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/62.jpg)
![Page 63: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/63.jpg)
CASE 4
• The PFTs show:
a. Normal spirometry and lung volumes
b. Obstructive pattern
c. Restrictive pattern
d. Mixed obstructive restrictive pattern
![Page 64: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/64.jpg)
![Page 65: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/65.jpg)
![Page 66: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/66.jpg)
CASE 4
• The PFTs show:
a. Normal spirometry and lung volumes
b. Obstructive pattern
c. Restrictive pattern
d. Mixed obstructive restrictive pattern
![Page 67: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/67.jpg)
STEP IV: ADDITIONAL TESTS:DLCO
BRONCHOPROVOCATIONWALK TESTING
![Page 68: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/68.jpg)
MEASURING GAS EXCHANGE: DLCO
Transfer of CO from
alveoli to blood is
diffusion limited:
CO binds hemoglobin 210
times more efficiently
than O2 and normally
very low concentration in
blood
Thus, limited by surface
area, membrane
thickness & blood
flow/Hb
![Page 69: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/69.jpg)
USE OF DLCO
• Restrictive Disease
• Low- intrinsic disease (parenchymal lung disease)
• Normal- extraparenchymal causes of restriction (obesity, neuromuscular disease, chest wall limitations)
• Obstructive Disease
• Low- emphysema
• Normal- asthma
• Isolated reduction in DLCO--> raises possibility of pulmonary vascular disease
![Page 70: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/70.jpg)
CAUSES OF REDUCED DLCO
Decreased surface area-Emphysema
Increased membrane thickness-Fibrosis
Decreased pulmonary blood volume
![Page 71: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/71.jpg)
AIRWAY RESPONSIVENESS
• Methacholine Challenge
• Obtain baseline FEV1
• Administer bronchoconstrictive agent, methacholine, at incremental doses until FEV1 drops by 20% or reach maximal dose (16mg/ml)
• Nebulize methacholine x2 min each dose then measure FEV1 at 30 and 90 sec after
• PC20 < 4mg/ml consistent with asthma (<1mg/ml is severe)
• PC20 >16mg/ml does not have asthma
ATS Guidelines, July 1999
![Page 72: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/72.jpg)
EXERCISE CAPACITY TESTING, THE 6MWT
![Page 73: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/73.jpg)
SIX MINUTE WALK TEST
• Measures exercise capacity NOT oxygen titration
• Used for:
• Pulmonary rehab
• Pulmonary hypertension response to advanced therapies
• Prognostication in IPF
• BODE index
• If you want to determine if your patient needs oxygen with exercise, order an oxygen titration study
![Page 74: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/74.jpg)
SUMMARY
PFTs are valuable tests for evaluating symptoms of dyspnea
1Approach interpretation with a systematic approach
2PFTs provide a pattern of physiologic impairment but do not make a diagnosis
3
![Page 75: INTERPRETATION OF PULMONARY FUNCTION TESTS (PFTS)](https://reader030.vdocuments.mx/reader030/viewer/2022012518/6192e119be59db2399575049/html5/thumbnails/75.jpg)
QUESTIONS/ ADDITIONAL PRACTICE CASES:
https://depts.washington.edu/uwmedres/Library/eLearning/Pulmonary/